Your browser doesn't support javascript.
loading
Don't delay, but don't despair: symptom duration, comorbidity and outcome after closure of spinal cerebrospinal fluid leaks.
Volz, Florian; El Rahal, Amir; Fung, Christian; Shah, Mukesch; Lützen, Niklas; Urbach, Horst; Beck, Jürgen; Wolf, Katharina.
Afiliação
  • Volz F; Department of Neurosurgery, Medical Center, University of Freiburg, Breisacher Strasse 64, 79106, Freiburg, Germany.
  • El Rahal A; Department of Neurosurgery, Medical Center, University of Freiburg, Breisacher Strasse 64, 79106, Freiburg, Germany.
  • Fung C; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Shah M; Department of Neurosurgery, Medical Center, University of Freiburg, Breisacher Strasse 64, 79106, Freiburg, Germany.
  • Lützen N; Department of Neurosurgery, Lindenhofspital, Bern, Switzerland.
  • Urbach H; Department of Neurosurgery, Medical Center, University of Freiburg, Breisacher Strasse 64, 79106, Freiburg, Germany.
  • Beck J; Department of Neuroradiology, Medical Center, University of Freiburg, Freiburg, Germany.
  • Wolf K; Department of Neuroradiology, Medical Center, University of Freiburg, Freiburg, Germany.
J Neurol ; 271(5): 2776-2786, 2024 May.
Article em En | MEDLINE | ID: mdl-38409537
ABSTRACT

OBJECTIVE:

Microsurgical sealing of spinal cerebrospinal fluid (CSF) leaks is a viable treatment option in spontaneous intracranial hypotension (SIH). Several factors may influence the outcome, with symptom duration probably the most modifiable variable.

METHODS:

Patients with closure of spinal CSF leaks between September 2020 and March 2023 and a follow-up period of 6 months were included in this retrospective single-center study. Pre- and postoperative scores for impact of headaches (Headache Impact Test, HIT-6) and quality of life (QoL, EQ-5D-5L) were systematically collected. Multiple regression modelling and subgroup analyses for different symptom durations and comorbidities were performed for these outcomes.

RESULTS:

One hundred patients (61% female, median age 43.5 years) were included. Six months postoperatively, there was significant improvement in headache impact (HIT-6 66 (IQR 62-69) to 52 (IQR 40-61, p < 0.001) and QoL (EQ-5D-5L VAS 40 (IQR 30-60) to 79 (IQR 60-90); EQ-5D-5L Index 0.67 (IQR 0.35-0.8) to 0.91 (IQR 0.8-0.94, p < 0.001, respectively). Subgroup analysis for a symptom duration above (74%) and below 90 days (26%) and comorbidity, as well as multiple regression analysis, revealed a trend in favor of early treatment and lower comorbidity. However, even after a prolonged symptom duration, improvements were significant.

CONCLUSION:

As patients with shorter symptom duration show a trend for a better outcome, our results promote a timely diagnosis and treatment in SIH patients. However, a significant postoperative improvement can still be expected even after a prolonged symptom duration.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Qualidade de Vida / Comorbidade / Vazamento de Líquido Cefalorraquidiano Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Qualidade de Vida / Comorbidade / Vazamento de Líquido Cefalorraquidiano Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha